Lupus trials recruiting in Ohio

All Lupus trials nationally

Cities in Ohio

Recruiting trials in Ohio

• A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
  NCT06308978 · Phase: Phase 1 · Ages: 12 Years to 70 Years · Sex: All (male and female) · Ohio: Cleveland
• A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
  NCT06570798 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Ohio: Cleveland
• A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
  NCT06576271 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Ohio: Columbus
• A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
  NCT07438496 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Ohio: Middleburg Heights
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
  NCT05039619 · Phase: Phase 2 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Ohio: Cincinnati
• A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
  NCT07409181 · Phase: Phase 2 · Ages: 18 Years to 74 Years · Sex: All (male and female) · Ohio: Middleburg Heights
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
  NCT05835310 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Columbus
• BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
  NCT06340750 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Ohio: Columbus
• Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
  NCT07089121 · Phase: Phase 1, Phase 2 · Ages: 12 Years and older · Sex: All (male and female) · Ohio: Cincinnati
• Lupus Landmark Study: A Prospective Registry and Biorepository
  NCT05934149 · Phase: Not specified · Ages: 18 Years to 110 Years · Sex: All (male and female) · Ohio: Cleveland
• Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
  NCT06133972 · Phase: Phase 3 · Ages: 12 Years to 100 Years · Sex: All (male and female) · Ohio: Middleburg Heights
• Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
  NCT07225387 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Ohio: Columbus
• Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
  NCT05268289 · Phase: Phase 2 · Ages: 18 Years to 100 Years · Sex: All (male and female) · Ohio: Cleveland
• Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN
  NCT06527872 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Columbus
• The BRIDGE Pain Study
  NCT07602595 · Phase: Not specified · Ages: 14 Years to 26 Years · Sex: All (male and female) · Ohio: Cincinnati
• The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
  NCT05538208 · Phase: Phase 2 · Ages: 8 Years to 20 Years · Sex: All (male and female) · Ohio: Akron, Cincinnati, Cleveland, Columbus
• Transforming Care for Individuals With Childhood-onset Systemic Lupus Erythematosus
  NCT06232304 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 22 Years · Sex: All (male and female) · Ohio: Cincinnati